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1. INTRODUCTION 
Neuroblastoma cells are a suitable model to in- 
vestigate some aspects of neuronal development 
because of their ability to extend neurites in res- 
ponse to a variety of stimuli. There are many 
agents and conditions which stimulate this neurite 
outgrowth [ 1,2]. However, the biochemical mecha- 
nisms underlying this event are not yet understood. 
Our observation that mouse neuroblastoma cells 
extend neurites when grown in a medium supple- 
mented with delipidated fetal calf serum suggests 
that alterations of membrane lipid composition 
may influence cell morphology [3]. Since the dis- 
covery of 2 different methyltransferases which cata- 
lyse the conversion of phosphatidylethanolamine 
into phosphatidylcholine using S-adenosylmethione 
(AdoMet) as methyl donor, much attention has 
been focussed on this biochemical event [4]. This 
stepwise methylation is involved in the control of 
numerous cellular functions such as changes in 
membrane fluidity [5], calcium transport [6], 
Ca2+-ATPase activity [7], IgE-mediated histamine 
and arachidonic acid release in rat leukemic baso- 
phils [S] and lectin-induced lymphocyte mito- 
genesis [9]. Hence it appears that phospholipid 
methylation may be an important event which 
regulates the transduction of receptor-mediated 
signals through the cell membrane [4]. Not all re- 
ceptor-mediated events, however, require this bio- 
chemical reaction [4, lo]. Inhibition of methylation 
has also been implicated in developmental cellu- 
lar events [ 111. For example, 3-deaza-adenosine 
(3-deazaAdo), an inhibitor of methylations, increa- 
ses the frequency of conversion of 3T3-Ll tibro- 
blasts to fat cells. Here, we report that inhibitors of 
AdoMet-linked methylation reactions efficiently 
induce neurite extension in parallel with their inhib- 
ition of phospholipid methylation in neuroblasto- 
ma cells. Furthermore, chemicals which are able to 
stimulate neurite extension (the calcium ionophore 
A23 187, mepacrine, cycloheximide, dibutyryl- 
cyclic AMP (dbcAMP) and 3-isobutyl- l-methyl- 
xanthine (IBMX)) also inhibit phospholipid 
methylation in intact neuroblastoma cells. Thus we 
suggest that inhibition of AdoMet-linked methyla- 
tion is a biochemical event which can lead to neurite 
outgrowth. 
2. MATERIALS AND METHODS 
2.1. Cell culture and bioassay for neurite outgrowth 
Mouse neuroblastoma cells, clone NBzA, were 
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3-deazaAdo, 3-deaza-adenosine); SIBA, 5’-deoxy-S-S- 
isobutyl-thioadenosine; dbcAMP, dibutyryl-cyclic AMP; 
IBMX, 3-isobutyl- I-methylxanthine 
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grown in Dulbecco’s modified Eagle’s medium 
(DMEM) which contained 10% fetal calf serum 
(FCS) at 37°C in a humidified 10% CO2-90% air 
atmosphere.,The cells were dislodged with EDTA 
and cells were inoculated at 3.5 x 104/culture 
dish (35 mm) containing 2 ml DMEM supple- 
mented with 10% FCS and cultures were incubated 
as above. After 16-18 h, the medium was replaced 
by 2 ml DMEM supplemented with tricine 
(3.6 X 10 -2 M) and NaHC03 (1.2 x 10 -2 M) 
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(TDMEM), containing 0.8% FCS, which had not 
been heat-inactivated but dialyzed against 0.9% 
NaCl solution, filter-sterilized and frozen. The bio- 
assay was done 24 h later by changing the medium 
to 2 ml fresh TDMEM with and without the 
substance to be tested. The ionophore A23 187 was 
used as an ethanolic solution and so 4 ~1 ethanol was 
added also to control dishes. After 4 h incubation 
the assay was terminated by aspirating away the 
medium and fixing the cells with 1.5 ml 2.5% glutar- 
aldehyde in phosphate-buffered saline [3]. The ex- 
tent of neurite outgrowth was determined as in [ 121. 
2.2. Phospholipid methylation 
Neuroblastoma cells were incubated under the 
same conditions as those of the bioassay for neurite 
outgrowth with the difference that 10 @Zi L-[methyl- 
3H]methionine (91 Ci/mmol, Amersham) dish 
was added twice, 2 h before and immediately after 
TDMEM + 0.8% FCS medium had been changed to 
2 ml TDMEM with and without the substance to be 
tested. At each indicated time point the reaction was 
stopped by removing the medium and adding 1.5 
ml 5% trichloroacetic acid. Cells were washed with 
1.5 ml same solution and detached from the dishes 
with a rubber policeman. The dishes were then 
washed with an additional 1 ml trichloroacetic acid. 
After addition of 40 ~1 bovine serum albumin solu- 
tion (1 mg/ml) and centrifugation at 6000 X g for 
10 min, the supernatant was discarded and phos- 
pholipids were extracted from the pellets with 3 ml 
chloroform/methanol (2:1, v/v) followed by 2 
washes with 2 ml 0.1 M KCl/SO% methanol solution 
as in [ 131. The solvent was evaporated with a stream 
of Nz, the residue was resuspended in scintillation 
fluid and assayed for radioactivity. In separate ex- 
periments phospholipid extracts from several dishes 
were combined and analyzed by a two-dimensional 
thin-layer chromatography on silica gel plates as in 
[ 141. The subsequent autoradiography revealed that 
radioactivity incorporated into the phospholipid 
fraction was located on 3 spots and that there was 
no radioactive spot seen at the origin. By co- 
developing phospholipid extracts with authentic 
samples the radioactive spots were assigned to 
phosphatidylcholine, lysophosphatidylcholine and 
a mixture of phosphatidyl-N-methyl- and phos- 
phatidyl-NJ-dimethylethanolamine. 
3. RESULTS 
To investigate a possible role of AdoMet-linked 
methylation in neurite extension by neuroblastoma 
cells, we first tested the effect of S-adenosyl-L-ho- 
mocysteine (AdoHcy), a specific competitive inhib- 
itor of methylations with AdoMet as methyl donor 
[ 151. To promote neurite extension, 2.4 x 10 -4 M 
AdoHcy was required (table 1). At 2.4 x 10 P3 M 
the effect was greatly enhanced and > 80% of cells 
formed neurites. The possibility that inhibition of 
methylation could lead to neurite outgrowth was 
further confirmed by the effect of other methyl- 
transferase inhibitors, 3-deazaAdo [4,1 I] and 
5’-deoxy-5’&isobutylthioadenosine (SIBA) [ 161 
(table 1). 3-DeazaAdo was the most effective and 
even at 3.7 x 10 -5 M, - 70% of neuroblastoma 
cells became morphologically differentiated. 
To determine whether phospholipid methylation 
is indeed suppressed by these inhibitors, we in- 
Table 1 
Effects of different chemicals on morphological diffe- 
rentiation of mouse neuroblastoma cells 
Cont. 
(M) 
Cells with 
neurites (W) 
Control 
AdoHcy 
3-DeazaAdo 
SIBA 
Ionophore A23 187 
Mepacrine 
Mellitin 
Cycloheximide 
DbcAMP 
IBMX 
14.3k5.1 
2.4x lO-3 82.5 k 0.3 
2.4x 10 -4 44.8 k 1.4 
3.7x 10-4 77.2 f 1.4 
3.7x 10-s 68.120.5 
5.0x IO-4 58.0+ 1.0 
2.0x 10-s 40.0 + 0.5 
3.8x lo-’ 73.5k4.6 
3.8X 10-s 69.7 + 3.3 
2.0 x 10 -6 59.62 7.6 
5.0x 10 -’ 32.4k4.0 
3.5x 10-7 Toxic 
1.8x lo-’ ll.lk3.6 
3.5 x 10 -8 20.0 f 3.5 
1.2x IO-6 70.8 f 0.3 
1.0x 10-s 64.6 2 1.3 
.0.9x 10-s 64.2 k 3.6 
0.9 x 10 -4 36.22 1.8 
With the exception of mellitin, none of the chemicals at 
the concentrations used here was toxic to the cells. Each 
value represents the mean f standard deviation of 
triplicate samples. 
322 
Volume 144, number 2 FEBS LETTERS August 1982 
1 2 3 
Time (hr) 
Fig. 1. Inhibitory effects of AdoHcy and 3-deazaAdo on 
the incorporation of [3H]methyl groups into phospho- 
lipids. Neuroblastoma cells were incubated with L- 
[-methyl-3H]methionine in the presence of either 
2.4 X lop3 M AdoHcy (0) or 3.7 x 10 14 M 3-deazaAdo 
(A). Controls are given as corresponding open symbols. 
Results expressed as the difference from the value at time 
zero represent the mean f standard deviation of tripli- 
cate samples. The [3H]methyl incorporations at time zero 
were 275 f 5 cpm/dish in the experiment for AdoHcy 
and 2 18 + 15 cpm/dish in that for 3-deazaAdo. 
cubated neuroblastoma cells with L-[methyl-‘HI- 
methionine under the conditions of the neurite out- 
growth assay and monitored phospholipid methyl- 
ation by measuring radioactivity incorporated in- 
to the phospholipid fraction. Both AdoHcy 
(2.4 x 10 -3 M) and 3-deazaAdo (3.7 x 10 -4 M) 
completely prevented incorporation of methyl 
groups into phospholipids at the concentrations at 
which they brought an optimal neurite extension 
(tig.1). The correlation of the inhibition of phos- 
pholipid methylation with the induction of neurite 
outgrowth was more closely examined. Neuro- 
blastoma cells were incubated for 2 h with various 
concentrations of 3-deazaAdo. The incorporation 
of f3H]methyl groups into phospholipid and the 
extent of neurite outgrowth were then determined 
4 
lo+ lo-’ 
’ -3 
10 
3-DeazaAdo ( M ) 
Fig.2. Inhibition of phospholipid methylation (O-O) 
and neurite outgrowth (0-a) induced by 3-deazaAdo. 
Mouse neuroblastoma cells were treated with various 
concentrations of 3-deazaAdo for 2 h. The incorporation 
of 13H]methyl groups into the phospholipid fraction and 
the extent of neurite outgrowth were determined as in 
section 2. In the absence of inhibitor the [3H]methyl in- 
corporation and the percentage ofcells with neurites were 
420 r 60 cpm/dish and 22 f 18, respectively. Each point 
is the mean + standard deviation of triplicate samples. 
(fig.2). 3-DeazaAdo affected both events with the 
same dose-response. The generality of the observed 
relationship between inhibition of phospho- 
lipid methylation and neurite outgrowth was also 
studied. The short time required to promote neurite 
extension in our assay condition made it possible to 
test the effect of substances which could elicit many 
secondary effects when applied for longer times. 
We selected various agents known to affect cellular 
biochemical events in a number of ways and tested 
their ability to promote both neurite extension 
and interference with phospholipid methylation 
in neuroblastoma cells. The calcium ionophore 
A23187, the antimalarial drug mepacrine (a phos- 
pholipase A2 inhibitor), dbcAMP and IBMX 
(agents that increase intracellular cyclic AMP con- 
tent), and cycloheximide (a protein synthesis in- 
hibitor) were chosen for this purpose (table 1 and 
fig.3). Low concentrations of ionophore A23187 
induced -70% of neuroblastoma cells to extend 
neurites as in [17]. Phospholipase A2 activity has 
been linked to phospholipid methylation [4,8,9]. It 
is thus interesting that 2.0 x 10 -’ M mepacrine 
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Fig.3. Effects of various chemicals on the incorporation 
of [3H]methyl groups into phospholipids: (0) experi- 
mental; (o) control data. Each point represents the mean 
+ standard deviation of triplicate samples: (a) 
3.8 x 1O-8 M ionophore A23187; (b) 2.0 x 10 -6 M 
mepacrine; (c) 1.2 x 10 -6 M cycloheximide; (d) 10 -3 M 
dbcAMP; (e) 0.9 x 10 -3 M IBMX. 
was as effective as the transmethylase inhibitors 
tested in causing neurite outgrowth. By contrast 
mellitin, a phospholipase A2 activator, appeared 
not to have any marked effect on cell morphology 
(table 1). These results could be the first indication 
for an involvement of phospholipase A2 activity in 
neurite extension. Substances which elevate intra- 
cellular cyclic AMP levels promote neurite exten- 
sion [ 1,2]. Using our assay, we confirmed that both 
dbcAMP and IBMX were able to stimulate > 60% 
of cells to form neurites (table 1). An increase in 
cyclic AMP levels alone, however, does not seem 
necessary for the initiation of changes in cell 
morphology. For example, a macromolecular factor 
released from glial cells promotes neurite out- 
growth without significantly affecting intracellular 
cyclic AMP levels [ 121. 
Cycloheximide antagonizes the neurite forma- 
tion induced by dbcAMP [18], whereas cyclohexi- 
mide alone, when applied in serum-free medium, 
promotes neurite extension [ 181. Under our assay 
conditions 1.2 X 10 -6 M cycloheximide induced 
70% of cells to grow neurites. The ways in which 
phospholipid methylation was affected by these 
chemicals are summarized in fig.3. At concentra- 
tions at which neurite outgrowth was efficiently stim- 
ulated, every substance caused a suppression of 
the incorporation of [3H]methyl groups into 
phospholipids, even though there were some dif- 
ferences in time course and degree of inhibition. The 
inhibitory effect of the ionophore A23187 
(3.8 x 10 -’ M) seems to last 2 3 h (fig.3a), 
whereas the inhibition caused by 2.0 x 10 -6 M 
mepacrine apparently disappears with time (lig.3b). 
Cycloheximide strikingly interfered with phospho- 
lipid methylation (fig.3c). Both dbcAMP and IBMX 
acted on phospholipid methylation in an inhibitory 
manner, but their effects were kinetically distinct 
(tig.3d,e). 
4. DISCUSSION 
The mechanisms by which neuroblastoma cells 
are stimulated to form neurites have not been un- 
equivocally identified. Here, we show that inhibitors 
of AdoMet-linked methylation efficiently induce 
neurite outgrowth in parallel with their inhibition of 
phospholipid methylation in neuroblastoma cells. 
The dose-dependent effect of 3-deazaAdo has not 
only confirmed a link between both events but also 
provided indication that neuroblastoma cells might 
require the inhibition of phospholipid methylation 
in order to extend neurites. Numerous substances 
are known to induce neurite outgrowth in neuro- 
blastoma cells. We have selected some of these and 
found all of them to inhibit phospholipid methyla- 
tion. This indicates that the correlation between 
neurite outgrowth and the inhibition of phospho- 
lipid methylation is not restricted to typical 
methylation inhibitors. The inhibition of phospho- 
lipid methylation seems rather to be a phenomenon 
closely linked to the growth of neurites in neuro- 
blastoma cells. 
Neurite extension induced by cycloheximide 
might be attributed to a decrease in activities of 
crucial methyltransferases as a consequence of the 
general inhibitory effect on protein synthesis. Our 
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observations that the ionophore A23187, mepa- 
crine, dbcAMP and IBMX affected phospholipid 
methylation in neuroblastoma cells are consistent 
with the reports showing a close link between cal- 
cium influx [6,19], phospholipase A2 activity [4,8,9], 
cyclic AMP levels [ 191 and phospholipid methyla- 
tion in different types of cells. Further studies are 
necessary to determine whether, in neuroblastoma 
cells, these biochemical steps act independently or. 
in concert with each other. 
In [20], addition of nerve growth factor (NGF) to 
explants of rat superior cervical ganglia caused a 
transient increase of the phospholipid methylation 
localized in the neurites. These findings, when 
analyzed in detail, do not seem incompatible with 
our observations. The explants of rat superior cer- 
vical ganglia are incubated first for 5 days with 
NGF. They are then starved of NGF and serum 
prior to and during the [methyl-3H]methionine la- 
beling. The transient increase in phospholipid 
methylation detected only in the neurites during the 
30 s following a new addition of NGF could reflect, 
for example, a biochemical event related to the 
uptake of NGF and not to the growth of the neur- 
ites. In fact the very short incubation time used in 
such experiments does not allow phospholipid 
methylation to be linked to neurite outgrowth. Our 
experiments monitor the methylation of phospho- 
lipids in neuroblastoma cells which have never ex- 
tended neurites before being triggered. Further, 
addition of glial conditioned medium known to ef- 
ficiently induce neurite extension in those cells [ 121 
does not seem to affect phospholipid methylation 
(not shown). This would indicate that inhibition of 
phospholipid methylation is not a prerequisite for 
neurite outgrowth. 
We cannot rule out that other methylation reac- 
tions (for example, protein methylation) are also 
affected by the methylases inhibitors or by the sub- 
stances inducing neurite outgrowth. Nevertheless, 
our results demonstrate that inhibition of Ado- 
Met-linked methylation induces neurite outgrowth 
and many different substances known to trigger this 
morphological change also inhibit phospholipid 
methylation in intact cells. Therefore, they suggest 
that with certain inducers, this biochemical event is 
closely linked to the membrane changes that must 
occur prior to or during the growth of neurites. 
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